Department of the National Health Service of UK in association with the NHS Business Services Authority have developed RTEC based drug dispensing platform.
The FDA has approved the anticoagulant Brilinta for use in patients with cardiovascular disease.
In a small study, a biotech company has tested its own amyotrophic lateral sclerosis drug.
On 22nd of September 2020 the company "Ananta Medicare" in association with "Clinic of modern rheumatology" held the first webinar on the topic of osteoporosis. The lecture "Osteoporosis - from idea to action" was conducted by prof. Egudina Elizaveta Davydovna.
Scenic Biotech founders and biologists have designed their own functional genomics platform to accurately identify genes that modify a specific disease.
The steroidogenesis inhibitor levoketoconazole has improved laboratory parameters in adult patients with endogenous Cushing's disease.
The World Health Organization expects to receive 2 billion doses of COVID-19 vaccines under the COVAX program in 2021.
Experts believe that GALAPAGOS and GILEAD have managed to make a breakthrough on an experimental autotoxin inhibitor in the field of scleroderma therapy.
Clinical studies on VIR-2218 have shown an effective result in the fight against hepatitis B.
The FDA has assigned an orphan drug status to a drug based on rhenium nanoliposom.